SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16013901
Source:
http://linkedlifedata.com/resource/pubmed/id/16013901
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0087111
,
umls-concept:C0360105
,
umls-concept:C0439231
,
umls-concept:C1705413
,
umls-concept:C1709305
pubmed:issue
7
pubmed:dateCreated
2005-7-14
pubmed:abstractText
Although adverse events are a key factor in compliance, their evolution during treatment with antidepressants is poorly documented. Therefore, the time course of adverse events during 6 months of antidepressant treatment was investigated.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7801243
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fluoxetine
,
http://linkedlifedata.com/resource/pubmed/chemical/Paroxetine
,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Uptake Inhibitors
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0160-6689
pubmed:author
pubmed-author:AlbertAdelinA
,
pubmed-author:De BruyckereKatrienK
,
pubmed-author:DemyttenaereKoenK
,
pubmed-author:DewéWalthèreW
,
pubmed-author:MestersPatrickP
,
pubmed-author:SangeleerMichèleM
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
859-63
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16013901-Adult
,
pubmed-meshheading:16013901-Adverse Drug Reaction Reporting Systems
,
pubmed-meshheading:16013901-Data Interpretation, Statistical
,
pubmed-meshheading:16013901-Depressive Disorder, Major
,
pubmed-meshheading:16013901-Double-Blind Method
,
pubmed-meshheading:16013901-Female
,
pubmed-meshheading:16013901-Fluoxetine
,
pubmed-meshheading:16013901-Humans
,
pubmed-meshheading:16013901-Male
,
pubmed-meshheading:16013901-Middle Aged
,
pubmed-meshheading:16013901-Outcome Assessment (Health Care)
,
pubmed-meshheading:16013901-Paroxetine
,
pubmed-meshheading:16013901-Patient Dropouts
,
pubmed-meshheading:16013901-Recurrence
,
pubmed-meshheading:16013901-Serotonin Uptake Inhibitors
,
pubmed-meshheading:16013901-Severity of Illness Index
,
pubmed-meshheading:16013901-Sex Factors
,
pubmed-meshheading:16013901-Time Factors
,
pubmed-meshheading:16013901-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?
pubmed:affiliation
Department of Psychiatry, University Hospital Gasthuisberg, Belgium. koen.demyttenaere@med.kuleuven.ac.be
pubmed:publicationType
Journal Article
,
Comparative Study